Australia Considers Delay In H1N1 Vaccine Distribution To Next Winter
This article was originally published in PharmAsia News
Executive Summary
The Australian government has decided to be cautious in releasing the millions of doses of H1N1 flu vaccine it has ordered from drug maker CSL. The vaccine is currently in clinical trials and reportedly proceeding smoothly through the process. CSL says its vaccine could be ready for distribution by the end of August, but the government could delay distributing from its stockpile until the nation's next winter season. The government already has ruled out early distribution to the elderly, patients with chronic illnesses and others considered vulnerable. (Click here for more
You may also be interested in...
Lack Of Industry Involvement In Scoping Process Exacerbates ‘Unworkable’ Timelines
Scientific advice could help companies make up for the lack of involvement in scoping, but slots are in short supply.
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.